The DOI matches its Crossref record; 72 of the 74 references it cites were found in a registry or an index.
ApoE Promotes the Proteolytic Degradation of Aβ
Open accessAbstract
Apolipoprotein E is associated with age-related risk for Alzheimer's disease and plays critical roles in Abeta homeostasis. We report that ApoE plays a role in facilitating the proteolytic clearance of soluble Abeta from the brain. The endolytic degradation of Abeta peptides within microglia by neprilysin and related enzymes is dramatically enhanced by ApoE. Similarly, Abeta degradation extracellularly by insulin-degrading enzyme is facilitated by ApoE. The capacity of ApoE to promote Abeta degradation is dependent upon the ApoE isoform and its lipidation status. The enhanced expression of lipidated ApoE, through the activation of liver X receptors, stimulates Abeta degradation. Indeed, aged Tg2576 mice treated with the LXR agonist GW3965 exhibited a dramatic reduction in brain Abeta load. GW3965 treatment also reversed contextual memory deficits. These data demonstrate a mechanism through which ApoE facilitates the clearance of Abeta from the brain and suggest that LXR agonists may represent a novel therapy for AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“APOE3 promotes enzyme-mediated degradation of A 𝛃 in microglia more efficiently than APOE4 (295), suggesting the APOE and microglia play a role in the innate immune response in AD (368).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [295]
In the citing paper
“In this regard, ApoE is indeed tightly connected to the turnover of Ab 1 -42 , since it plays a critical role in the normal proteolytic clearance of Ab 1 -42 (14).”
From SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease (2014) · cites this paper as [14]
In the citing paper
“One recent in vitro study found that human apoE isoforms differed in their ability to facilitate neprilysin-mediated degradation of Aβ42 within microglia, with apoE4 being the least effective in facilitating Aβ degradation compared to apoE2 or apoE3 (60).”
From Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) · cites this paper as [60]
In the citing paper
“Several studies demonstrated that apoE isoforms can differentially affect Aβ clearance (Deane et al., 2008; Jiang et al., 2008; Castellano et al., 2011).”
From Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis (2011) · cites this paper as Jiang et al., 2008
In the citing paper
“In addition, several studies have shown that activation of Lxr increases mouse apoE and decreases Aβ levels (Jiang et al., 2008).”
From Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis (2011) · cites this paper as Jiang et al., 2008
In the citing paper
“LXR agonist treatment alleviates AD-like pathology in mouse models of amyloidosis, possibly by inducing Abca1 expression (29, 43–48).”
From The E3 ubiquitin ligase Idol controls brain LDL receptor expression, ApoE clearance, and Aβ amyloidosis (2015) · cites this paper as [29]
In the citing paper
“In addition to its role in A secretion, ABCA1 has been also shown to decrease A levels by promoting extracellular A clearance in both neurons and glial cells (Jiang et al., 2008;Kim et al., 2012).”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Jiang et al., 2008
In the citing paper
“A previous report demonstrated that extracellular A degradation by proteases, such as insulin-degrading enzyme, is influenced by the lipidation status of ApoE (Jiang et al., 2008).”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Jiang et al., 2008
In the citing paper
“ApoE lipidation by ABCA1 is critical for A clearance (Jiang et al., 2008;Kim et al., 2012).”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Jiang et al., 2008
In the citing paper
“we and others have shown that ABCA1 is required for the effective clearance of A by neuronal and glial cells”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Jiang et al., 2008
In the citing paper
“A recent in vitro study demonstrated that the presence of fully lipidated apoE is required for effective degradation of Aβ in microglia (Jiang et al., 2008; Terwel et al., 2011).”
From miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression (2012) · cites this paper as Jiang et al., 2008
In the citing paper
“More recent studies in transgenic mouse models of AD have shown that microglia migrate to amyloid plaques and may alter plaque growth dynamics (9–12).”
From Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice (2013) · cites this paper as [10]
In the citing paper
“ABCA1-mediated lipidation of apoE may play a key role in facilitating Aβ degradation by Aβ-degrading enzymes (Jiang et al., 2008).”
From Apolipoprotein E in Synaptic Plasticity and Alzheimer’s Disease: Potential Cellular and Molecular Mechanisms (2014) · cites this paper as Jiang et al., 2008
In the citing paper
“In addition, treatment of several AD Tg mice models with liver X receptor or retinoid X receptor agonists, which upregulate ApoE expression and enhance its lipidation status, resulted in reduction of Ab plaque load through enhancing clearance of Ab by glial cells.43,44”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [43]
In the citing paper
“These published data indicate that the ApoE/Ab interaction may result in multidirectional effects that may promote Ab degradation by nonneuronal cells 43,44 while enhancing Ab accumulation in neurons.”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [43]
In the citing paper
“Short-term administration of LXR agonists TO901317 and GW3965 to 5-month-old preplaque Tg2576 mice improved fear conditioning (Riddell et al., 2007;Jiang et al., 2008)”
From Critical Role of Astroglial Apolipoprotein E and Liver X Receptor-α Expression for Microglial Aβ Phagocytosis (2011) · cites this paper as Jiang et al., 2008
In the citing paper
“Long-term treatment with GW3965 has been shown to reduce plaque formation by 50% in aged Tg2576 mice (Jiang et al., 2008).”
From Critical Role of Astroglial Apolipoprotein E and Liver X Receptor-α Expression for Microglial Aβ Phagocytosis (2011) · cites this paper as Jiang et al., 2008
In the citing paper
“Previously, it has been observed that the LXR agonist GW3965 stimulates degradation of soluble A in astroglial and microglial cultures dependent on ApoE and its lipidation status (Jiang et al., 2008).”
From Critical Role of Astroglial Apolipoprotein E and Liver X Receptor-α Expression for Microglial Aβ Phagocytosis (2011) · cites this paper as Jiang et al., 2008
In the citing paper
“Importantly, apoE-containing HDL particles facilitate the proteolytic degradation of soluble Aβ (sAβ) (Jiang et al., 2008).”
From Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease (2012) · cites this paper as Jiang et al., 2008
In the citing paper
“We report that astrocytes have the capacity to take up sAβ and degrade it in an apoE-dependent manner, similar to microglia (Figs. 1, 2; Jiang et al., 2008).”
From Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease (2012) · cites this paper as Jiang et al., 2008
In the citing paper
“We have previously documented that apoE acts to facilitate the proteolysis of soluble Aβ peptides both in the interstitial fluid and intracellularly by microglia through the actions of IDE and neprilysin, respectively (Jiang et al., 2008).”
From Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease (2012) · cites this paper as Jiang et al., 2008
In the citing paper
“Lipidated ApoE has anti-inflammatory effects and promotes Aβ metabolism (12)”
From Nuclear SphK2/S1P signaling is a key regulator of ApoE production and Aβ uptake in astrocytes (2024) · cites this paper as [12]
In the citing paper
“the administration of RXR or LXR agonists reduces Aβ aggregation and restores cognitive function in AD mouse model (11, 12)”
From Nuclear SphK2/S1P signaling is a key regulator of ApoE production and Aβ uptake in astrocytes (2024) · cites this paper as [12]
In the citing paper
“Lipidated ApoE has anti-inflammatory effects and promotes Aβ metabolism (12)”
From Nuclear SphK2/S1P signaling is a key regulator of ApoE production and Aβ uptake in astrocytes (2024) · cites this paper as [12]
In the citing paper
“Two in vitro studies have also demonstrated that apoE can facilitate the cellular degradation of Aβ (Jiang et al., 2008; Koistinaho et al., 2004).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Jiang et al., 2008
In the citing paper
“suggesting that ABCA1 affects Aβ clearance via apoE (Jiang et al., 2008).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Jiang et al., 2008
In the citing paper
“A recent in vitro study demonstrated that the presence of fully lipidated apoE was necessary for effective degradation of Aβ in microglia, suggesting that ABCA1 affects Aβ clearance via apoE (Jiang et al., 2008).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Jiang et al., 2008
In the citing paper
“One common hypothesis states that APOE sequesters soluble Aβ in the extracellular space resulting in cellular uptake and catabolism of this neurotoxic peptide. This hypothesis is supported by many in vitro studies (Koistinaho et al., 2004; Morikawa et al., 2005; Jiang et al., 2008).”
From The Pro-Neurotrophin Receptor Sortilin Is a Major Neuronal Apolipoprotein E Receptor for Catabolism of Amyloid-β Peptide in the Brain (2013) · cites this paper as Jiang et al., 2008
In the citing paper
“In the brain, endocytic pathways in glia cells (likely the LDL receptor) and in neurons are implicated in cellular catabolism of APOE/Aβ complexes (Koistinaho et al., 2004; Jiang et al., 2008; Holtzman et al., 2012).”
From The Pro-Neurotrophin Receptor Sortilin Is a Major Neuronal Apolipoprotein E Receptor for Catabolism of Amyloid-β Peptide in the Brain (2013) · cites this paper as Jiang et al., 2008
In the citing paper
“ApoE4 cells are less efficient in promoting intracellular A42 degradation compared with ApoE3 cells (Jiang et al., 2008).”
From ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes (2019) · cites this paper as Jiang et al., 2008
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,526
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 2×
“, 1995) and exhibit extensive deposits of Aβ by one year of age (Kawarabayashi et al., 2001).”
BackgroundMetabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C. J., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 982
Liver X receptors as integrators of metabolic and inflammatory signaling
Zelcer, N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27883 · Cited by 978
Self-citationIwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y., et al. (2000) · Nature Medicine · doi:10.1038/72237 · Cited by 867
Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830
Flagged first, then by citations
2 of the 74 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–875 of 875
Oligomeric amyloid-beta as a potential biomarker for Alzheimer's disease
Venkataraman, L. (2013)
Rodriguez, G. A. (2014) · DigitalGeorgetown (Georgetown University Library)
Novel regulation of neuronal genes implicated in Alzheimer disease by microRNA
Long, J. M. (2013) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2052
The association of concussion history and mental health in former collegiate athletes
Kerr, Z. Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/97pa-hp30
Symptom Attribution, Injury Severity, and Catastrophic Ideation in Postconcussional Disorder
Whitfield, K. (2013) · Summit (Simon Fraser University)
Ramanan, V. K., & Saykin, A. J. (2013)
Alzheimer’s Disease Therapeutics Targeting Apolipoprotein E
Liao, F., & Holtzman, D. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00010-1
Self-citationPrice, D. L., Savonenko, A. V., Li, T., & Wong, P. C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.009
Neurohormetic Properties of the Phytochemical Resveratrol
Holme, A. L., & Pervaiz, S. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch21
Predictive Genetic Testing Using Common Variants: Evidence and Translation
Chan, H. T. H. (2016)
Analysis of liver X receptor target gene expression across species
Noto, P. B., & Bentz, J. E. (2013) · iDEA - Drexel University Institutional Repository · doi:10.17918/etd-4198
MODELING DEMENTIA RISK, COGNITIVE CHANGE, PREDICTIVE RULES IN LONGITUDINAL STUDIES
Ding, X. (2016) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2016.336
Dorey, E. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-6258
Stem Cells in Alzheimer’s Disease Therapy
Patharagulpong, A. (2017) · Stem cells in clinical applications · doi:10.1007/978-3-319-33720-3_3
O'Regan, J. (2014) · TSpace (University of Toronto)
Metabolic study of Alzheimer’s disease using mutant C. elegans
Ahmad, W. (2017) · The University of Queensland · doi:10.14264/uql.2017.500
Expression, purification and biophysical characterization of human Presenilin 2
Yang, G. (2013) · JuSER (Forschungszentrum Jülich)
Estrogen Receptor β Regulates Brain Signaling Involved in Depression
Chhibber, A. (2016) · KU ScholarWorks (The University of Kansas)
Genetic factors associated with human extremely longevity; Focusing on centenarian study
優也, 赤., & 計, 神. (2018) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.55.554
Modak, S. (2013) · Research Explorer (The University of Manchester)
Oxidative modification of vesicular transporters in an animal model of Alzheimer’s disease
Wang, Y. (2015) · Mspace (University of Manitoba)
Recombinant AAV Gene Therapy and Delivery
Carty, N. (2009) · Digital Commons - University of South Florida (University of South Florida)
Clinical Research Progress of Alzheimer’s Disease
李, 晓. (2020) · Advances in Clinical Medicine · doi:10.12677/acm.2020.1010341
Genetic and functional studies of genes involved in the pathogenesis of Alzheimer's disease
Natunen, T. (2014) · UEF eRepo (University of Eastern Finland)
The interactive impact of omega-3 fatty acids, APOE genotype and sex hormones on cognition
Pontifex, M. G. (2020) · UEA Digital Repository (University of East Anglia)
Wei, Z., Qi, X., Zhai, S., Chen, Y., Xia, X., Zheng, B., Sun, X., Zhang, G., Wang, L., Zhang, Q., et al. (2020) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2019-0213
Jackson, T. A., & Najem, M. S. (2012) · Digital WPI
Transcriptional and Posttranscriptional Control of Cholesterol Homeostasis by Liver X ReceptorsPreprint
Ontonoz, P. T. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010702 · Cited by 47
Self-citationCarrasquillo, M. M., Bu, G., & Nielsen, H. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7309-1_2
Clinical Applications of Aspirin
Schrör, K. (2016) · Wiley eBooks · doi:10.1002/9783527685059.ch4
(2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804538-1.00036-5
Washington, P. M., Villapol, S., & Burns, M. P. (2019) · Cambridge University Press eBooks · doi:10.1017/9781139696432.015
Apolipoprotein E4 Prevalence in Different Canine Breeds
(2022) · International Journal of Veterinary Science · doi:10.47278/journal.ijvs/2021.123 · Cited by 1
Molecular diagnosis of Alzheimer’s disease
Lin, X. (2022) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v14i.1834
Choi, Y., Shin, S., Son, H. J., Lee, N.-H., Myeong, S. H., Lee, C., Jang, H., Choi, S. J., Kim, H. J., & Na, D. L. (2023) · Figshare · doi:10.6084/m9.figshare.23714256
Self-citationAnalysis of transporter activity in an Alzheimer’s disease blood-brain barrier cell model
Chaves, J. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.248279
Relationship Between Dyslipidemia and Alzheimer’s Disease
Bolayırlı, M., & Kücür, M. (2024) · doi:10.69860/nobel.9786053359166.12
ApoE and Brain Synaptic Dynamics
Huang, Z. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_68-1
Whole-exome sequencing identifies 5 novel genes associated with carpal tunnel syndrome
Wang, Z.-Y., He, X., Wu, B., Liu, Y., You, J., Liu, W., Feng, J., Cheng, W., & Yu, J. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf076
Apolipoprotein E (APOE) Isoforms and Neurobiology of Sporadic Alzheimer’s Disease
Mollica, A., Berardino, G., Bellomo, A., Altamura, M., Panza, F., & Lozupone, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_155
In Silico Design of APOE ɛ4 Interaction Inhibitor Peptides for Alzheimer’s DiseasePreprint
Ji, J., Han, E., Park, J., Son, A., & Kim, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.03.673973
Taverna, M. (2014) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.17796
REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR SPLICING EFFICIENCY
Ling, I. (2009) · UKnowledge (University of Kentucky)
Additional file 1 of APOE effects on regional tau in preclinical Alzheimer’s disease
Young, C. B., Johns, E., Kennedy, G., Belloy, M. E., Insel, P. S., Greicius, M. D., Sperling, R. A., Johnson, K. A., Poston, K. L., & Mormino, E. C. (2023) · Figshare · doi:10.6084/m9.figshare.22608413
Choi, Y., Shin, S., Son, H. J., Lee, N.-H., Myeong, S. H., Lee, C., Jang, H., Choi, S. J., Kim, H. J., & Na, D. L. (2023) · Figshare · doi:10.6084/m9.figshare.23714250
Self-citationAdditional file 12 of Impact of APOE genotype on prion-type propagation of tauopathy
Williams, T., Ruiz, A. J., Ruiz, A. M., Vo, Q., Tsering, W., Xu, G., McFarland, K., Giasson, B. I., Sullivan, P. M., Borchelt, D. R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19619142
Choi, Y., Shin, S., Son, H. J., Lee, N.-H., Myeong, S. H., Lee, C., Jang, H., Choi, S. J., Kim, H. J., & Na, D. L. (2023) · Figshare · doi:10.6084/m9.figshare.23714253
Self-citationRole of apolipoprotein E4 in alzheimer’s disease pathogenesis and emerging therapeutic strategies
Natarajan, S., & Saraswathy, S. D. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01761-0
Systemic Amyloid-β Metabolism in Alzheimer’s Disease
Dong-yu, F., Wang, J., Gu, B. J., Masters, C. L., & Wang, Y. (2026) · Springer eBooks · doi:10.1007/978-981-95-5222-1_7
A Review of Interaction Between Sleep Apnea and APOE e4 on the Risk of Dementia
Ding, X., Watwood, C., Patel, A., Hegde, K., Mahanna, B., Escudero, L., & Neils-Strunjas, J. (2026) · Journal of Gerontology and Geriatrics · doi:10.3390/jgg74010004
Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer
Laumet, G. O. (2010) · theses.fr (ABES) · doi:10.70675/94126786zf990z488ezb471z5f1d5686766c
Vascular and respiratory impact in neurodegenerative diseases
Zmudka, J. (2017) · theses.fr (ABES) · doi:10.70675/9adb83e1z9fdfz4b08z9f4dz0c2b0dfee38f
Hanbouch, L. (2017) · theses.fr (ABES) · doi:10.70675/c4d2c894zf69dz4ae4z9ab1zf4135d0efa12
Nuclear receptors in age-related diseases: From mechanisms to drug discovery
Zhang, L., Li, X., Ren, C., Hao, Y., Deng, Y., Pan, H., Kim, Y.-B., Fan, S., Huang, C., Ge, G., et al. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103125 · Cited by 1
Li, D., Zhang, Y., Wang, R., Jin, L., Cui, X., Hong, J.-S., Li, S., Zhao, J., & Guo, Y. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00899
Rôle central des glucocorticoïdes et de leurs récepteurs dans l’étiologie de la Maladie d’Alzheimer
Canet, G. (2020) · theses.fr (ABES) · doi:10.70675/c46cedbczd8bbz4a8eza301z82de5785048c
Joint Reconstruction of Longitudinal Positron Emission Tomography Studies for Tau Protein Imaging
Tiss, A. (2019) · theses.fr (ABES) · doi:10.70675/c487be06z4e17z48c0za864zfe62a434cd75
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Lam, S. (2021) · theses.fr (ABES) · doi:10.70675/60b353ffz56fcz41a2z9e53zf0d9ac078167 · Cited by 1
Développement d’un test sanguin pour le dépistage de la maladie d’Alzheimer
Torres, F. D. (2022) · theses.fr (ABES) · doi:10.70675/afbb97a5z1636z46abz844czb340616aeda1
Fukui, M., Kaise, T., Masaki, T., Sakamoto, T., & Kageyama, R. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117250
Rodrigues, K. S., Yamashita, R., & Katada, S. (2026) · Frontiers in Neural Circuits · doi:10.3389/fncir.2026.1818927
Angeloni, E., Germelli, L., Marchetti, L., Pozzo, E. D., Wetzel, C. H., Settimo, F. D., Taliani, S., Trincavelli, M. L., Martini, C., & Costa, B. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168279
Multi-organ imaging genetics: towards an integrated view of brain, body and brain diseases
Fan, Z., & Zhao, B. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01276-x
Shi, H., Zhao, Y., Wei, Z., Yan-jiang, W., & Bu, X.-L. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.09.009
Metadata
- Authors
- Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., Richardson, J. C., Smith, J. D., Comery, T. A., Riddell, D., Holtzman, D. M., Tontonoz, P., & Landreth, G. E.
- Affiliations
- Case Western Reserve University (US)
- Howard Hughes Medical Institute (US)
- Cleveland Clinic (US)
- GlaxoSmithKline (United Kingdom) (GB)
- Wyeth (US)
- Washington University in St. Louis (US)
- Corresponding author
- Landreth, Gary E.
- ORCID
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 58
- Issue
- 5
- Pages
- 681-693
- ISSN
- 0896-6273 (ISSN-L)
- PMC
- PMC2493297
- OpenAlex
- W1994554610
- Cited by
- 876
- References
- 74
- Citations by year
- 2026: 15 · 2025: 34 · 2024: 33 · 2023: 37 · 2022: 35 · 2021: 42 · 2020: 42 · 2019: 47 · 2018: 46 · 2017: 50 · 2016: 57 · 2015: 60 · 2014: 70 · 2013: 70 · 2012: 56
- FWCI
- 41.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute on Aging (R01AG013956, R01AG020202, AG020202, R01AG030482, F32AG24031, F32AG024031, R37AG013956, AG13956)
- National Heart, Lung, and Blood Institute (HL3 0568, P01HL030568, R01HL066082, R01HL066088, HL66088)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- apolipoprotein E, amyloid-beta, neprilysin, insulin-degrading enzyme, microglia, APOE isoforms, lipid modification, liver X receptor, GW3965, Tg2576 mice, Alzheimer's disease, memory impairment
- MeSH terms
- Liver X Receptors, Aging, Alzheimer Disease, Animals, Animals, Newborn, Apolipoproteins E, Behavior, Animal, Benzoates, Benzylamines, Brain, Cells, Cultured, Disease Models, Animal, DNA-Binding Proteins, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, Memory, Mice, Inbred C57BL, Mice, Transgenic, Peptide Fragments, Time Factors, Amyloid beta-Peptides, Microglia, Receptors, Cytoplasmic and Nuclear, ATP-Binding Cassette Transporters, Mice, Orphan Nuclear Receptors, Plaque, Amyloid, ATP Binding Cassette Transporter 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
